D7033Z0
Beam Radiation Lymphatics, Neck to Intraoperative with None, Electrons Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | D Radiation Therapy |
| Body System | 7 Lymphatic and Hematologic System |
| Operation | 0 Beam Radiation |
| Body Part | 3 Lymphatics, Neck |
| Approach | 3 Electrons |
| Device | Z None |
| Qualifier | 0 Intraoperative |
Procedure Overview
Beam radiation to the lymphatic and hematologic system delivers external radiation, typically from a linear accelerator, to lymph node regions or hematologic tissue affected by cancers such as Hodgkin lymphoma, non-Hodgkin lymphoma, or localized involvement from leukemia. Treatment is usually planned as a fractionated course given over several weeks, with the total dose divided into smaller daily sessions to maximize tumor control while allowing normal tissue to recover between treatments.
It is used both as primary therapy for certain lymphomas confined to specific nodal regions and as consolidation after chemotherapy to eliminate residual disease in previously bulky sites. Patients typically receive planning imaging beforehand to map the treatment field precisely to the involved nodal chain.
Anatomy & Axis Detail
Lymphatics, Neck
The cervical lymphatic chains drain the head, neck, oral cavity, and thyroid, and are frequently involved by lymphoma, head and neck squamous cell carcinoma, or thyroid malignancy, making them a common target for regional nodal irradiation. Beam radiation to the neck lymphatics is planned around numerous adjacent structures, including the spinal cord, salivary glands, larynx, and carotid vessels, so field design and shielding are critical to limit xerostomia, dysphagia, and long-term vascular injury. Treatment may address a single palpable nodal level or an entire nodal basin depending on disease extent and whether the approach is definitive or adjuvant to surgery. Documentation should identify the specific nodal levels or chains encompassed by the field, since this distinguishes limited from comprehensive neck irradiation.
Modality Qualifier: Electrons
Electrons identifies electron-beam therapy, which delivers a rapid dose falloff after a limited depth and is favored for superficial tumors, skin cancers, or boosts near the surface such as chest wall or scar treatment. Unlike Photons >10 MeV, which continue depositing dose deep into tissue, electrons spare underlying structures once their range is exhausted, making them the modality of choice when sparing deeper organs matters more than penetration.
Qualifier: Intraoperative
This qualifier indicates that radiation therapy is delivered intraoperatively, meaning the radiation dose is administered during surgery directly to the treatment site rather than in a separate outpatient session. It distinguishes this single-dose surgical delivery approach from conventional fractionated radiation therapy, which carries the None qualifier.
Coding & Documentation
Coders need documentation specifying the treatment site (a named lymph node region, spleen, or other hematologic structure), the modality as external beam, and the qualifier describing the type of beam, such as photon or electron therapy, drawn from the radiation oncology treatment plan and daily treatment records.
A common error is coding the diagnosis-driven anatomic site rather than the actual field treated, since radiation fields are often described in oncology shorthand like "mantle field" or "involved-site radiotherapy" that must be translated to the correct body part value. Failing to capture the correct qualifier for beam type is another frequent gap when the treatment summary isn't reviewed closely.